220 related articles for article (PubMed ID: 29871934)
1.
Hill MA; Alexander WB; Guo B; Kato Y; Patra K; O'Dell MR; McCall MN; Whitney-Miller CL; Bardeesy N; Hezel AF
Cancer Res; 2018 Aug; 78(16):4445-4451. PubMed ID: 29871934
[TBL] [Abstract][Full Text] [Related]
2. MYC determines lineage commitment in KRAS-driven primary liver cancer development.
D'Artista L; Moschopoulou AA; Barozzi I; Craig AJ; Seehawer M; Herrmann L; Minnich M; Kang TW; Rist E; Henning M; Klotz S; Heinzmann F; Harbig J; Sipos B; Longerich T; Eilers M; Dauch D; Zuber J; Wang XW; Zender L
J Hepatol; 2023 Jul; 79(1):141-149. PubMed ID: 36906109
[TBL] [Abstract][Full Text] [Related]
3. Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma.
Guest RV; Boulter L; Kendall TJ; Minnis-Lyons SE; Walker R; Wigmore SJ; Sansom OJ; Forbes SJ
Cancer Res; 2014 Feb; 74(4):1005-10. PubMed ID: 24310400
[TBL] [Abstract][Full Text] [Related]
4. p53R245W Mutation Fuels Cancer Initiation and Metastases in NASH-driven Liver Tumorigenesis.
Dibra D; Gagea M; Qi Y; Chau GP; Su X; Lozano G
Cancer Res Commun; 2023 Dec; 3(12):2640-2652. PubMed ID: 38047594
[TBL] [Abstract][Full Text] [Related]
5. Clonal tracing of Sox9+ liver progenitors in mouse oval cell injury.
Tarlow BD; Finegold MJ; Grompe M
Hepatology; 2014 Jul; 60(1):278-89. PubMed ID: 24700457
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide profiling of transcription factor activity in primary liver cancer using single-cell ATAC sequencing.
Craig AJ; Silveira MAD; Ma L; Revsine M; Wang L; Heinrich S; Rae Z; Ruchinskas A; Dadkhah K; Do W; Behrens S; Mehrabadi FR; Dominguez DA; Forgues M; Budhu A; Chaisaingmongkol J; Hernandez JM; Davis JL; Tran B; Marquardt JU; Ruchirawat M; Kelly M; Greten TF; Wang XW
Cell Rep; 2023 Nov; 42(11):113446. PubMed ID: 37980571
[TBL] [Abstract][Full Text] [Related]
7. Genomic Analysis in the Categorization of Poorly Differentiated Primary Liver Carcinomas.
Kikuchi AT; Umetsu S; Joseph N; Kakar S
Am J Surg Pathol; 2023 Nov; 47(11):1207-1218. PubMed ID: 37661782
[TBL] [Abstract][Full Text] [Related]
8. Molecular and radiopathologic spectrum between HCC and intrahepatic cholangiocarcinoma.
Jeon Y; Kwon SM; Rhee H; Yoo JE; Chung T; Woo HG; Park YN
Hepatology; 2023 Jan; 77(1):92-108. PubMed ID: 35124821
[TBL] [Abstract][Full Text] [Related]
9. N-cadherin: A diagnostic marker to help discriminate primary liver carcinomas from extrahepatic carcinomas.
Gerber TS; Ridder DA; Goeppert B; Brobeil A; Stenzel P; Zimmer S; Jäkel J; Metzig MO; Schwab R; Martin SZ; Kiss A; Bergmann F; Schirmacher P; Galle PR; Lang H; Roth W; Straub BK
Int J Cancer; 2024 May; 154(10):1857-1868. PubMed ID: 38212892
[TBL] [Abstract][Full Text] [Related]
10. Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
Pomyen Y; Chaisaingmongkol J; Rabibhadana S; Pupacdi B; Sripan D; Chornkrathok C; Budhu A; Budhisawasdi V; Lertprasertsuke N; Chotirosniramit A; Pairojkul C; Auewarakul CU; Ungtrakul T; Sricharunrat T; Phornphutkul K; Sangrajang S; Loffredo CA; Harris CC; Mahidol C; Wang XW; Ruchirawat M;
Sci Rep; 2023 Jul; 13(1):11406. PubMed ID: 37452065
[TBL] [Abstract][Full Text] [Related]
11. Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications.
Martin-Serrano MA; Kepecs B; Torres-Martin M; Bramel ER; Haber PK; Merritt E; Rialdi A; Param NJ; Maeda M; Lindblad KE; Carter JK; Barcena-Varela M; Mazzaferro V; Schwartz M; Affo S; Schwabe RF; Villanueva A; Guccione E; Friedman SL; Lujambio A; Tocheva A; Llovet JM; Thung SN; Tsankov AM; Sia D
Gut; 2023 Apr; 72(4):736-748. PubMed ID: 35584893
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of HMGB1 in hepatocytes accelerates PTEN inactivation-induced liver cancer.
Athavale D; Barahona I; Song Z; Desert R; Chen W; Han H; Das S; Ge X; Komakula SSB; Gao S; Lantvit D; Guzman G; Nieto N
Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38055645
[TBL] [Abstract][Full Text] [Related]
13. Smad4 restricts injury-provoked biliary proliferation and carcinogenesis.
Alexander WB; Wang W; Hill MA; O'Dell MR; Ruffolo LI; Guo B; Jackson KM; Ullman N; Friedland SC; McCall MN; Patel A; Figueroa-Guilliani N; Georger M; Belt BA; Whitney-Miller CL; Linehan DC; Murphy PJ; Hezel AF
Dis Model Mech; 2024 Jun; 17(6):. PubMed ID: 38415925
[TBL] [Abstract][Full Text] [Related]
14. TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk.
Lam YK; Yu J; Huang H; Ding X; Wong AM; Leung HH; Chan AW; Ng KK; Xu M; Wang X; Wong N
Hepatology; 2023 Sep; 78(3):727-740. PubMed ID: 36221953
[TBL] [Abstract][Full Text] [Related]
15. Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice.
Zhang J; Lin XT; Yu HQ; Fang L; Wu D; Luo YD; Zhang YJ; Xie CM
Exp Mol Med; 2023 Oct; 55(10):2162-2176. PubMed ID: 37653031
[TBL] [Abstract][Full Text] [Related]
16. Chronic liver injury alters driver mutation profiles in hepatocellular carcinoma in mice.
Riordan JD; Feddersen CR; Tschida BR; Beckmann PJ; Keng VW; Linden MA; Amin K; Stipp CS; Largaespada DA; Dupuy AJ
Hepatology; 2018 Mar; 67(3):924-939. PubMed ID: 28961327
[TBL] [Abstract][Full Text] [Related]
17. Loss of TP53 cooperates with c-MET overexpression to drive hepatocarcinogenesis.
Zhou Y; Cui G; Xu H; Chun J; Yang D; Zhang Z; Yang L; Wang J; Wan M; Calvisi DF; Lin S; Chen X; Wang H
Cell Death Dis; 2023 Jul; 14(7):476. PubMed ID: 37500626
[TBL] [Abstract][Full Text] [Related]
18. TFEB regulates murine liver cell fate during development and regeneration.
Pastore N; Huynh T; Herz NJ; Calcagni' A; Klisch TJ; Brunetti L; Kim KH; De Giorgi M; Hurley A; Carissimo A; Mutarelli M; Aleksieva N; D'Orsi L; Lagor WR; Moore DD; Settembre C; Finegold MJ; Forbes SJ; Ballabio A
Nat Commun; 2020 May; 11(1):2461. PubMed ID: 32424153
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Pathology of Intrahepatic Cholangiocarcinoma.
Choi JH; Thung SN
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672619
[TBL] [Abstract][Full Text] [Related]
20. Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADD.
Yang L; Niu K; Wang J; Shen W; Jiang R; Liu L; Song W; Wang X; Zhang X; Zhang R; Wei D; Fan M; Jia L; Tao K
J Hepatol; 2024 Apr; ():. PubMed ID: 38679071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
